General Physician or Paediatrician or Immunologist Diagnosis No Which must be Specialty verified Exclusion Solid organ transplantation Listed exclusions will refer queries to the The following conditions should not be Criteria B cell depletion therapy appropriate section within the written version or approved this indication: Thymoma-associated hypogammaglobulinaemia (Goods the Ig system. Syndrome) Transplantation-related immunomodulatory therapy ; (kidney and other solid organ transplantation). ; . Indication wording has largely been retained. The Indication Prevention of recurrent bacterial infections due to Prevention of recurrent bacterial for use hypogammaglobulinemia associated with Indication for HSCT confirmed eligibility is only infections due to antibody failure haematological malignancies. after HSCT has been completed and that HSCT does not need to be performed for associated with haematological Prevention of recurrent bacterial infections due to haematological malignancy. HSCT is not unusual in malignancies. hypogammaglobulinemia post HSCT children for non malignant reasons, these patients are cared for by haematologists and SWG Prevention of recurrent bacterial recommends retention under the same condition infections in patients undergoing HSCT to avoid confusion by prescribers. (A) for haematological malignancies.
General Physician or Paediatrician or Immunologist Diagnosis must be verified No Which Specialty Exclusion Criteria The following conditions should not be approved this indication: ; ; . Solid organ transplantation B cell depletion therapy Thymoma-associated hypogammaglobulinaemia (Goods Syndrome) Transplantation-related immunomodulatory therapy (kidney and other solid organ transplantation). Listed exclusions will refer queries to the appropriate section within the written version or the Ig system. Indication for use Prevention of recurrent bacterial infections due to antibody failure associated with haematological malignancies. Prevention of recurrent bacterial infections in patients undergoing HSCT for haematological malignancies. Prevention of recurrent bacterial infections due to hypogammaglobulinemia associated with haematological malignancies. Prevention of recurrent bacterial infections due to hypogammaglobulinemia post HSCT Indication wording has largely been retained. The Indication for HSCT confirmed eligibility is only after HSCT has been completed and that HSCT does not need to be performed for haematological malignancy. HSCT is not unusual in children for non malignant reasons, these patients are cared for by haematologists and SWG recommends retention under the same condition to avoid confusion by prescribers. (A)
secondary-hypogammaglobulinaemia-related-to-haematological-malignancies-and-post-haemopoietic-stem-cell-transplantation_1.DOCX